Filtered By:
Management: Government
This page shows you your search results in order of relevance. This is page number 10.
Order by Relevance | Date
Total 334 results found since Jan 2013.
India Scraps Funding Ties With Gates Foundation on Immunisation India Scraps Funding Ties With Gates Foundation on Immunisation
A group backed by the Bill and Melinda Gates Foundation that works on India ' s immunization programs will now be funded by the health ministry, a government official said, a move in part prompted by fears foreign donors could influence policy making.Reuters Health Information
Source: Medscape Allergy Headlines - February 9, 2017 Category: Allergy & Immunology Tags: Public Health & Prevention News Source Type: news
Trump's pick to lead health agency calls EpiPen issue 'disturbing'
WASHINGTON (Reuters) - U.S. President Donald Trump's choice to lead an important health agency said on Thursday that the way pharmaceutical companies classify products as generic or branded needs to be reviewed in order to help hold down government spending, as she cited Mylan NV's EpiPen emergency allergy treatment.
Source: Reuters: Health - February 16, 2017 Category: Consumer Health News Tags: healthNews Source Type: news
Trump's Pick To Lead Health Agency Calls EpiPen Issue 'Disturbing'
U.S. President Donald Trump’s choice to lead an important health agency said on Thursday that the way pharmaceutical companies classify products as generic or branded needs to be reviewed in order to help hold down government spending, as she cited Mylan NV’s EpiPen emergency allergy treatment.
Seema Verma, Trump’s nominee to lead the Centers for Medicare and Medicaid Services (CMS), did not answer questions about whether the U.S. government should negotiate with pharmaceutical companies over drug prices.
“I think what happened with ... the EpiPen issue is very disturbing,” Verma said at her c...
Source: Healthy Living - The Huffington Post - February 17, 2017 Category: Consumer Health News Source Type: news
Smoke and Mirrors: Beijing Battles to Control Smog Message Smoke and Mirrors: Beijing Battles to Control Smog Message
In its ' war ' on hazardous air pollution, China ' s government has a dilemma: it needs to be open about air quality data to hold polluters to account, but worries that too much bad news from alternative, independent sources could stoke public unrest.Reuters Health Information
Source: Medscape Allergy Headlines - February 17, 2017 Category: Allergy & Immunology Tags: Public Health & Prevention News Source Type: news
Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles
AbstractProgress has been made in the harmonization of efficacy and safety outcome measures for allergen immunotherapy (AIT) trials, but unresolved issues still remain. Furthermore, there are discrepancies in recommendations from professional medical societies and regulatory agencies regarding requirements for AIT trials. In this article, we reviewed published recommendations and current data from recent clinical trials, as well as the criteria applied by regulatory authorities for approval of AIT products, to provide updated considerations for conducting phase 3 AIT trials. Topics discussed include analysis of outcomes an...
Source: Current Allergy and Asthma Reports - March 13, 2017 Category: Allergy & Immunology Source Type: research
One Little Girl Beat The Deadliest Form Of Tuberculosis. She Is Very Lucky.
WASHINGTON ― When Baltimore resident Arjun kisses his 6-year-old daughter’s forehead, it’s not always just a sign of affection.
His daughter, Sujata, is onto him. “Is that a temperature kiss?” she asks.
Arjun compulsively checks his little girl’s temperature for a reason. Sujata is the survivor of the “first well-described case” of extensively drug-resistant tuberculosis in a young child in the U.S., according to her physicians.
Tuberculosis is the world’s biggest killer among infectious diseases, and extensively drug-resistant tuberculosis ― or XDR-TB, which is re...
Source: Healthy Living - The Huffington Post - March 24, 2017 Category: Consumer Health News Source Type: news
Mylan underpayment on EpiPen could exceed proposed settlement -study
NEW YORK (Reuters) - The amount that drugmaker Mylan NV avoided paying the U.S. government in Medicaid rebates for its EpiPen emergency allergy treatment since 2007 likely exceeds a proposed $465 million settlement the company announced in October, according to a study by private drug pricing experts published on Monday.
Source: Reuters: Health - March 27, 2017 Category: Consumer Health News Tags: healthNews Source Type: news
Scientists Start Second Phase Of Zika Vaccine Testing
Researchers at Houston’s Baylor College of Medicine last week began Phase 2 clinical trials for a Zika vaccine that is expected to have results as early as the end of this year.
Andrew Pekosz, a professor of microbiology and immunology at Johns Hopkins University’s Bloomberg School of Public Health, praised the vaccine’s potential to prevent disease, as well as how quickly clinical trials have taken place.
“It’s really been a light-speed endeavor,” Pekosz, who was not involved in the vaccine’s testing or development at the National Institute for Allergy and In...
Source: Science - The Huffington Post - April 3, 2017 Category: Science Source Type: news
Mylan Hit With New Class Action Lawsuit Over EpiPen Pricing
Mylan NV (MYL.O) has been hit with a new proposed class action lawsuit over the price of its EpiPen allergy treatment, which shot up to more than $600 for a two-pack of the device from less than $100 in 2007.
The lawsuit was filed on Monday in Tacoma, Washington, federal court by three EpiPen purchasers. It claims Mylan engaged in a scheme with pharmacy benefit managers, or PBMs - companies that act as intermediaries between pharmacies, insurers and drug companies - to dominate the market and overcharge consumers.
Although other lawsuits have been filed over EpiPen pricing, Monday’s is the first to focus on the role ...
Source: Healthy Living - The Huffington Post - April 4, 2017 Category: Consumer Health News Source Type: news
MACRA Changes Government Approach to Doctor Payment
New approach pays providers based on quality, value, and results delivered, but questions remain
Source: Pulmonary Medicine News - Doctors Lounge - April 8, 2017 Category: Respiratory Medicine Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, ENT, Pathology Source Type: news
354 Consumer self-testing of coloring mixtures is not useful for prediction of oxidative hair dye-related contact allergy
Oxidative hair dyes containing paraphenylenediamine (PPD) frequently used in Japan. The Japanese government has recommended self-testing by consumers with a mixture of oxidative dye and developer before hair coloring, and manufacturers of hair coloring agents are obliged to recommend self-testing in their product instruction leaflets. In 2015, however, a consumer monitoring survey of 3000 consumers by the Japanese Consumer Affairs Agency revealed that only 2% of them performed self-testing before hair coloring.
Source: Journal of Investigative Dermatology - April 12, 2017 Category: Dermatology Authors: T. Suzuki, Y. Masui, A. Ito, R. Abe Tags: Clinical Research: Patient Outcomes Research Source Type: research
The World Is Not Ready for the Next Pandemic
Across China, the virus that could spark the next pandemic is already circulating. It’s a bird flu called H7N9, and true to its name, it mostly infects poultry. Lately, however, it’s started jumping from chickens to humans more readily–bad news, because the virus is a killer. During a recent spike, 88% of people infected got pneumonia, three-quarters ended up in intensive care with severe respiratory problems, and 41% died.
What H7N9 can’t do–yet–is spread easily from person to person, but experts know that could change. The longer the virus spends in humans, the better the chance that i...
Source: TIME.com: Top Science and Health Stories - May 4, 2017 Category: Consumer Health News Authors: Bryan Walsh Tags: Uncategorized CDC Disease ebola Gates Foundation MERS outbreak pandemic Zika Source Type: news
U.S. Suspends Aid to Kenyan Health Ministry Over Corruption Concerns U.S. Suspends Aid to Kenyan Health Ministry Over Corruption Concerns
The U.S. government has suspended $21 million in direct aid to Kenya ' s Ministry of Health amid concern over corruption, the embassy said on Tuesday, giving emphasis to an issue that is a growing liability for the government before August elections.Reuters Health Information
Source: Medscape Allergy Headlines - May 10, 2017 Category: Allergy & Immunology Tags: HIV/AIDS News Source Type: news
